1,5‐Benzodiazepines as a platform for the design of carbonic anhydrase inhibitors - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Archiv der Pharmazie / Chemistry in Life Sciences Année : 2022

1,5‐Benzodiazepines as a platform for the design of carbonic anhydrase inhibitors

Résumé

A series of novel N-triazolo-benzene sulfonamides-1,5-benzodiazepines 9a–d and 10d were designed and prepared through the copper-catalyzed azide alkyne cycloaddition click chemistry procedure, reacting the N1-propargyl-1,5-benzodiazepine 2 and the N1,N5-dipropargyl analog 6 with various benzene sulfonamide azides 8a–d. The synthesized compounds were found to show nanomolar affinity toward relevant isoforms of human carbonic anhydrase such as hCA I, II, IV, VII, IX, and XII. The divalent derivative 10d showed a particularly high inhibitory activity against all hCA isoforms when compared with acetazolamide, and showed potent multivalent effects, better than reported previously for divalent CA inhibitors.
Fichier non déposé

Dates et versions

hal-03526748 , version 1 (14-01-2022)

Identifiants

Citer

Chiraz Ismail, Alessio Nocentini, Claudiu Supuran, Jean‐yves Winum, Rafik Gharbi. 1,5‐Benzodiazepines as a platform for the design of carbonic anhydrase inhibitors. Archiv der Pharmazie / Chemistry in Life Sciences, 2022, 355 (3), pp.2100405. ⟨10.1002/ardp.202100405⟩. ⟨hal-03526748⟩
36 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More